Insider Transactions in Q3 2023 at G1 Therapeutics, Inc. (GTHX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 08
2023
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct |
60,000
-17.67%
|
$120,000
$2.01 P/Share
|
|
Aug 08
2023
|
Mark A. Velleca |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+13.54%
|
$0
$0.35 P/Share
|
|
Jul 05
2023
|
John E. (Jack) Bailey Jr. President and CEO |
SELL
Open market or private sale
|
Direct |
2,719
-0.62%
|
$5,438
$2.45 P/Share
|
|
Jul 05
2023
|
Rajesh Malik Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,361
-0.99%
|
$2,722
$2.45 P/Share
|
|
Jul 05
2023
|
Terry L Murdock Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,361
-1.91%
|
$2,722
$2.45 P/Share
|
|
Jul 05
2023
|
Andrew Perry Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
355
-0.63%
|
$710
$2.45 P/Share
|